You are here

Academy of Managed Care Pharmacy Publishes Paper On Pharmaceutical Pricing Structures

ALEXANDRIA, Va., April 21 /PRNewswire/ -- The Academy of Managed Care Pharmacy (AMCP) has published an online document on its website detailing the complex and confusing pricing structure that governs pharmaceutical distribution practices.

The drug distribution chain consists of numerous levels and includes transactions between manufacturers, wholesalers, retailers and consumers. In addition, specific regulations affect drug pricing in relation to federal and state purchasing programs. Different terms are used to characterize costs or prices of drugs at these various levels within the distribution chain, and in some instances different terms used in describing transactions can refer to the same dollar amount.

"The cost of pharmaceuticals is a focus of attention at both the state and federal level, as government struggles to provide this valuable resource to its citizens who most need the assistance," said Mark Brueckl, the Pharmacy Affairs manager who assembled the data for the paper. "AMCP developed this document to assist its members and other interested parties in defining drug pricing terms and to explain how and when they are used in the pharmaceutical distribution system." The paper, which contains terminology, mathematical models and distribution diagrams, will be available to anyone with access to a computer. To read the paper, visit the AMCP website at http://www.amcp.org/professional_res/dpd.pdf.

Recent Headlines

U.S., Australia, and Canada Approve Endometrial Cancer Regimen
Single daily pill combines hypertension, cholesterol drugs
Drug With Androgen Deprivation Therapy Cut Risk of Death by 33% Compared With Placebo + ADT
A Diabetes Drug For People Without Diabetes
Roche Drug Outperformed Standard of Care in Phase 2 Study
One in Five Kids’ Office Visits Results in an Off-Label Rx
Related Settlement Would End Many but Not All Lawsuits
Chronic Kidney Patients With Hyperphosphatemia May Be Another Market for the Drug
Nitrosamine Impurity Also Affects Other Ranitidine Drugs